Ratios Uncovered: Breaking Down BridgeBio Pharma Inc (BBIO)’s Trailing Twelve Months Metrics

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

The price of BridgeBio Pharma Inc (NASDAQ: BBIO) closed at $29.50 in the last session, up 2.47% from day before closing price of $28.79. In other words, the price has increased by $2.47 from its previous closing price. On the day, 1.6 million shares were traded. BBIO stock price reached its highest trading level at $29.53 during the session, while it also had its lowest trading level at $28.36.

Ratios:

We take a closer look at BBIO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.19 and its Current Ratio is at 3.19.

On September 04, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $46.Piper Sandler initiated its Overweight rating on September 04, 2024, with a $46 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 19 ’24 when Kumar Neil sold 27,389 shares for $22.41 per share. The transaction valued at 613,826 led to the insider holds 4,897,443 shares of the business.

STEPHENSON BRIAN C sold 4,156 shares of BBIO for $93,137 on Nov 19 ’24. The Secretary, Treasurer & CFO now owns 93,758 shares after completing the transaction at $22.41 per share. On Nov 19 ’24, another insider, BRIAN STEPHENSON, who serves as the Officer of the company, bought 4,156 shares for $22.35 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BBIO now has a Market Capitalization of 5575204864 and an Enterprise Value of 7050153984. For the stock, the TTM Price-to-Sale (P/S) ratio is 27.65. Its current Enterprise Value per Revenue stands at 32.375 whereas that against EBITDA is -13.826.

Stock Price History:

Over the past 52 weeks, BBIO has reached a high of $44.32, while it has fallen to a 52-week low of $21.62. The 50-Day Moving Average of the stock is 16.64%, while the 200-Day Moving Average is calculated to be 9.81%.

Shares Statistics:

According to the various share statistics, BBIO traded on average about 2.13M shares per day over the past 3-months and 3348790 shares per day over the past 10 days. A total of 188.99M shares are outstanding, with a floating share count of 147.54M. Insiders hold about 21.93% of the company’s shares, while institutions hold 76.12% stake in the company. Shares short for BBIO as of 1731628800 were 17187425 with a Short Ratio of 8.09, compared to 1728950400 on 17779813. Therefore, it implies a Short% of Shares Outstanding of 17187425 and a Short% of Float of 13.96.

Most Popular